Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid - Test2 - elhamkhani - TriplyDB

Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid

Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid

http://www.wikidata.org/entity/Q24685517

about

9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice Structural and functional characterization of a novel type of ligand-independent RXR-USP receptor Electrostatic modulation in steroid receptor recruitment of LXXLL and FXXLF motifs The retinoid X receptors and their ligands The structure of the ultraspiracle ligand-binding domain reveals a nuclear receptor locked in an inactive conformation Structure-based analysis of the ultraspiracle protein and docking studies of putative ligands Nuclear receptors in bone physiology and diseases Metals and breast cancer Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism The structural basis of acyl coenzyme A-dependent regulation of the transcription factor FadR The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12 Crystal structure of the HNF4 alpha ligand binding domain in complex with endogenous fatty acid ligand Structural and functional insights into the ligand-binding domain of a nonduplicated retinoid X nuclear receptor from the invertebrate chordate amphioxus Activation of RXR–PPAR heterodimers by organotin environmental endocrine disruptors Structure, Energetics, and Dynamics of Binding Coactivator Peptide to the Human Retinoid X Receptor α Ligand Binding Domain Complex with 9- cis -Retinoic Acid The Orphan Nuclear Receptor TR4 Is a Vitamin A-activated Nuclear Receptor Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor The “Phantom Effect” of the Rexinoid LG100754: Structural and Functional Insights Structural Basis for Retinoic X Receptor Repression on the Tetramer In-plate protein crystallization, in situ ligand soaking and X-ray diffraction (+)-Rutamarin as a Dual Inducer of Both GLUT4 Translocation and Expression Efficiently Ameliorates Glucose Homeostasis in Insulin-Resistant Mice Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers The Crystal Structure of the Orphan Nuclear Receptor NR2E3/PNR Ligand Binding Domain Reveals a Dimeric Auto-Repressed Conformation Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor Ligand Binding Domain Sulindac-Derived RXRα Modulators Inhibit Cancer Cell Growth by Binding to a Novel Site Advances in drug design with RXR modulators An Endogenous Mammalian Retinoid X Receptor Ligand, At Last!TGIF inhibits retinoid signaling Investigation of ligand interactions with human RXRalpha by hydrogen/deuterium exchange and mass spectrometry.Retinoic acid actions through mammalian nuclear receptors.Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway.Creation and discovery of ligand-receptor pairs for transcriptional control with small molecules Cloning retinoid and peroxisome proliferator-activated nuclear receptors of the Pacific oyster and in silico binding to environmental chemicals.A critical role of helix 3-helix 5 interaction in steroid hormone receptor function Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis Ligand-protein interactions in nuclear receptors of hormones.Interactions that determine the assembly of a retinoid X receptor/corepressor complex.Structural basis for HNF-4alpha activation by ligand and coactivator binding.Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors.

P2860

Q21092399-4C092939-DFEF-4C5E-90A4-CF5F29EC51E5 Q24336232-49D1CD66-5B55-47EE-B7CB-CFB52C3E2354 Q24550576-B1E9CB02-5B1C-4888-8D42-3E9505B5D807 Q24562747-F2CE8A78-E1B8-4A11-AA31-DDD42BD4164D Q24623615-7B7642B8-C188-484F-85B3-F05417EABD13 Q24798825-E10BEA77-343A-402E-A36D-A1267877146E Q26853017-788E57F5-E4A5-43F2-AEAD-CC2C4368273E Q26995153-8F80B301-34E5-4B26-B3EB-48576FD7639F Q27627719-C946B04E-C0BB-4031-A77E-7E48117F99AF Q27630889-301CFDB7-47A3-4DE7-8FC2-76255D9C169F Q27631126-B4B73C2B-B4BE-408F-A769-9FE614A50DAB Q27637227-A3E5C68A-C700-41AA-8393-9DEF2A35E7C1 Q27639521-F518F2E5-CD29-4988-BCBC-21C791FBC2BD Q27652780-FF30EF12-DDF5-498F-AE4D-3CAF5C71065F Q27654040-20BCFEE6-C182-407B-B077-892B9C0F2164 Q27665595-72D36FD3-46EA-4D4F-A84F-AD11EFCDB14A Q27665760-60C733B5-88D5-4633-9BF9-2B7B1CF798FB Q27665948-DAA44F7D-EC55-473D-85B4-F51153D6E610 Q27666286-C05048BA-2EF1-4EB9-9409-5A1C37167523 Q27668012-E9390372-C1AF-4A2A-8433-9FD7D4DE5444 Q27673449-535BFA03-0E52-4071-A516-2A43BE0FCE19 Q27677636-47DD3550-62B5-4FD0-9CAD-4D0A8072D75B Q27678318-AD815558-352F-43D6-99A1-A6D88A452016 Q27680068-9FC67920-B414-46D1-92F4-67AA20275F2E Q27680515-6372D380-AE32-4961-B85D-68BEFE93F849 Q27682952-8BA75CE6-1F8B-4575-9BEA-EC864265CE8C Q28274388-A931A5D4-1548-4AF5-9145-930836E3D539 Q28275389-A78D3900-01EE-4B9D-9215-C23C420FD413 Q28590970-F28F26CA-0980-4D29-A3C7-C6BC897F401A Q30355962-F5053011-4B0D-4CA3-AECA-CEC16807BD99 Q30408649-B5BEB566-FD17-467D-893F-E5EA1046A9EC Q30938708-023C095D-756F-47B3-8C82-E14A35B7C5CB Q33207495-7974B88D-5B80-4F8F-BF92-E702CC94BE1E Q33584820-B0AD8D6A-0C24-45F0-9783-2C4AC1AFCC5C Q33864134-66CA7E4F-4206-4C69-9AA4-D3844C919332 Q33900787-3A54D023-8092-44BA-A061-FF9E97894EC7 Q33957129-8F9E4F90-969C-445B-9EE8-6EA7CDBF51EE Q34026902-966BEE7E-BDED-437C-BDE0-5BBC24000F0B Q34300855-41579813-2F4E-4367-8520-39215E9A94CD Q34351189-44960D68-C5F2-460F-985D-07F03B1494E8

P2860

Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid

http://www.wikidata.org/entity/Q24685517

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@ast

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@en

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@nl

type

label

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@ast

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@en

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@nl

prefLabel

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@ast

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@en

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@nl

P1433

Q24685517-B92E0892-C305-49C0-9932-7944CD1D349A

P1476

Q24685517-2E512F45-3F6A-43B9-9DF5-F4C6314E9B55

P2093

Q24685517-19F39BDE-E9F3-471B-8CCF-BAC417E28932

Q24685517-78D552F4-A683-434D-8040-6F520367B5DF

Q24685517-DAA988B6-3367-40A1-A957-DDFE7D1E3372

Q24685517-E7098901-4DD7-4502-AA43-1A9AAAE0C76F

Q24685517-EBC531B4-BEF4-4D83-91D5-C1F395BC1E3D

P2860

Q24685517-0EBEB952-9932-4408-BFA0-3BBF82B38097

Q24685517-1372DFEF-7F14-45AE-B3B0-554E7A654B3C

Q24685517-202B706D-707D-4743-B9E8-7A62FB3DEB99

Q24685517-29CAFADA-D6C1-4A81-8D2B-17E8E6B25767

Q24685517-2A8856EC-01E2-4306-9B10-D492BF4D3F18

Q24685517-2AB5E31C-251C-4683-AB72-1D1911EBA3D4

Q24685517-36919E90-E51B-446F-A12E-20F493474455

Q24685517-49AD06FE-86FD-4518-9B46-77AF7995B765

Q24685517-4B0C8B36-BDBC-4066-9691-7C93E5CF98D4

Q24685517-54C4D62A-C098-45B6-93CA-813D308B4D77

P304

Q24685517-79798653-CBF8-4286-8B88-8604E9EECB01

P31

Q24685517-7067267C-CC85-46FF-BA8C-5E2200896820

P3181

Q24685517-72930B3D-D2A0-4052-93A3-605C10EE4D26

P356

Q24685517-14071725-C4B6-419A-A88B-AEE4626370E3

P407

Q24685517-9F6D1D35-2E05-4E01-A6A4-51F1229ECF15

P433

Q24685517-8EA590C4-2A08-428D-BCE5-9E01A5990975

P478

Q24685517-F72448CE-ED84-40DA-8FAF-E0556A8BD5B3

P50

Q24685517-13F7F3EB-E577-4023-B292-6F252E76D10A

P577

Q24685517-B19D5990-1ED0-4420-A704-13BAA6744E10

P5875

Q24685517-4CC1C461-9F5D-430D-88EA-5A98046DA496

P698

Q24685517-A2F598D9-2E31-42BD-A247-D33909FCA749

P921

Q24685517-00A07EAA-BA01-4680-A6E3-75A3840BEDBE

Q24685517-3827816D-5C53-4437-B55E-BF30AF3021CA

P932

Q24685517-F06F6097-13A1-4313-BAAD-AC4AEEEFFA93

P3181

P356

P1433

The EMBO Journal

P1476

Crystal structure of the human ...... al ligand: 9-cis retinoic acid

@en

P2093

A Mitschler

http://www.w3.org/2001/XMLSchema#string

D Moras

http://www.w3.org/2001/XMLSchema#string

M Ruff

http://www.w3.org/2001/XMLSchema#string

N Rochel

http://www.w3.org/2001/XMLSchema#string

P F Egea

http://www.w3.org/2001/XMLSchema#string

P2860

The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand

Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids

Improved methods for building protein models in electron density maps and the location of errors in these models

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains

Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid

Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha

Molecular basis of agonism and antagonism in the oestrogen receptor

Conformational adaptation of agonists to the human nuclear receptor RAR gamma

Atomic structure of progesterone complexed with its receptor

P304

2592-601

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2778520

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/EMBOJ/19.11.2592

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12483568

http://www.w3.org/2001/XMLSchema#string

P698

10835357

http://www.w3.org/2001/XMLSchema#string

P921

crystal structure

P932

212755

http://www.w3.org/2001/XMLSchema#string